Previous Close | 48.29 |
Open | 48.55 |
Bid | 49.85 x 900 |
Ask | 49.95 x 1200 |
Day's Range | 48.55 - 50.39 |
52 Week Range | 40.94 - 61.71 |
Volume | |
Avg. Volume | 20,818,059 |
Market Cap | 281.235B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 9.75 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.60 (3.19%) |
Ex-Dividend Date | Jul 28, 2022 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for PFE
MARKET PULSE Pfizer Inc. (pfe) CEO Albert Bourla tested positive for COVID-19. He tweeted Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE (bntx) is "experiencing very mild symptoms" and has started taking Paxlovid, Pfizer's COVID-19 antiviral.
The Pfizer CEO says he has received four doses of his company’s Covid-19 vaccine. Albert Bourla said he had begun taking a course of Paxlovid, his company’s Covid-19 antiviral.
Pfizer Inc Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms. Bourla, 60, said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. "I am confident that I will have a speedy recovery," Bourla said in a statement.